This inventor holds 1 USPTO granted patent and 8 published patent applications and 1 EPO patent. Top assignee: Heptares Therapeutics Limited. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Rebecca Paul
Introduction
Rebecca Paul is an accomplished inventor based in Cambridge, GB. She has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds that target somatostatin receptors. Her work has the potential to impact the treatment of various disorders associated with these receptors.
Latest Patents
Rebecca Paul holds a patent for "Cyclohexapeptides as selective somatostatin SST5 receptor agonists." This patent discloses novel compounds of a specific formula and their salts, which are designed for use in treating, preventing, ameliorating, controlling, or reducing the risk of disorders associated with somatostatin receptors. This innovation highlights her expertise in creating targeted therapeutic agents.
Career Highlights
Rebecca is currently employed at Heptares Therapeutics Limited, where she continues to advance her research in drug development. Her work at this company has positioned her as a key player in the field of pharmaceutical innovation.
Collaborations
Some of her notable coworkers include Giles Albert Brown and Miles Stuart Congreve. Their collaborative efforts contribute to the ongoing research and development initiatives at Heptares Therapeutics Limited.
Conclusion
Rebecca Paul's innovative work in the field of medicinal chemistry exemplifies the impact of targeted therapies in modern medicine. Her contributions continue to pave the way for advancements in the treatment of disorders related to somatostatin receptors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile